Literature DB >> 25675400

1,2,4-triazole derivatives as potential scaffold for anticonvulsant activity.

Vipan K Kamboj, Prabhakar K Verma, Anu Dhanda, Sudhir Ranjan1.   

Abstract

The search for new anticonvulsant agent with more selectivity and lower toxicity continues to be an area of rigorous investigation in medicinal chemistry. Epilepsy is a chronic disorder of brain whose treatment consists of controlling seizures with antiepileptic drugs that very often related with side-effects which in rare circumstances can be potentially life-threatening. Triazolam and Alprazolam are established drugs used in epilepsy which have triazole moiety. The potency and broad spectrum of the pharmacological response of triazole moiety as anticonvulsant agent have attracted the attention of medicinal chemists to explore this framework for its potential. The literature shows that different substitution on triazole ring exhibit potent antiepileptic activity with no or lesser neurotoxicity. The present review is a sincere attempt to compile the reported potent triazole derivatives with significant anticonvulsant action.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25675400     DOI: 10.2174/1871524915666150209100533

Source DB:  PubMed          Journal:  Cent Nerv Syst Agents Med Chem        ISSN: 1871-5249


  6 in total

1.  Derivatives of a new heterocyclic system - pyrano[3,4-c][1,2,4]triazolo[4,3-a]pyridines: synthesis, docking analysis and neurotropic activity.

Authors:  Ervand G Paronikyan; Anthi Petrou; Maria Fesatidou; Athina Geronikaki; Shushanik Sh Dashyan; Suren S Mamyan; Ruzanna G Paronikyan; Ivetta M Nazaryan; Hasmik H Hakopyan
Journal:  Medchemcomm       Date:  2019-06-19       Impact factor: 3.597

2.  Synthesis and Biological Activities of Ethyl 2-(2-pyridylacetate) Derivatives Containing Thiourea, 1,2,4-triazole, Thiadiazole and Oxadiazole Moieties.

Authors:  Daniel Szulczyk; Piotr Tomaszewski; Michał Jóźwiak; Anna E Kozioł; Tadeusz Lis; David Collu; Filippo Iuliano; Marta Struga
Journal:  Molecules       Date:  2017-03-06       Impact factor: 4.411

3.  2-[(3-Aminoalkyl-(alkaryl-,aryl-))-1H-1,2,4-triazol-5-yl]anilines: synthesis and anticonvulsant activity.

Authors:  Yulya Martynenko; Galina Berest; Nina Bukhtiayrova; Igor Belenichev; Oleksiy Voskoboinik; Sergiy Kovalenko
Journal:  Turk J Chem       Date:  2020-06-01       Impact factor: 1.239

4.  Discovery of novel dual adenosine A1/A2A receptor antagonists using deep learning, pharmacophore modeling and molecular docking.

Authors:  Mukuo Wang; Shujing Hou; Yu Wei; Dongmei Li; Jianping Lin
Journal:  PLoS Comput Biol       Date:  2021-03-19       Impact factor: 4.475

5.  New Application of 1,2,4-Triazole Derivatives as Antitubercular Agents. Structure, In Vitro Screening and Docking Studies.

Authors:  Zbigniew Karczmarzyk; Marta Swatko-Ossor; Waldemar Wysocki; Monika Drozd; Grazyna Ginalska; Anna Pachuta-Stec; Monika Pitucha
Journal:  Molecules       Date:  2020-12-19       Impact factor: 4.411

Review 6.  Recent developments on triazole nucleus in anticonvulsant compounds: a review.

Authors:  Ming-Xia Song; Xian-Qing Deng
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.